This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Jill N. Johanson
Introduction
Jill N. Johanson is a prominent inventor based in Cranford, NJ, who has made significant contributions to the field of pharmaceutical sciences. As a dedicated professional at Merck & Company, Inc., Jill has focused her research on advancing our understanding of chemokine receptors, leading to valuable innovations in therapeutics.
Latest Patents
Jill holds one patent titled "4-alkyl piperidinyl pyrrolidine modulators of chemokine receptor activity." This patent showcases her expertise in developing compounds that may influence chemokine receptor behavior, which has implications in various medical fields, particularly in targeting immune responses.
Career Highlights
Throughout her career, Jill has demonstrated a commitment to research and innovation within the pharmaceutical industry. Her work at Merck & Company, Inc. reflects both her collaborative spirit and her drive to contribute to meaningful advancements in healthcare. By developing novel compounds, she plays an essential role in addressing unmet medical needs.
Collaborations
Jill has had the opportunity to work alongside talented colleagues such as Jennifer Chee and Frank Kayser. These collaborations help enhance the creativity and effectiveness of research efforts at Merck, fostering an environment where innovative ideas can flourish.
Conclusion
Jill N. Johanson exemplifies the impact of innovative thinking in the realm of pharmaceutical research. Her patent and collaborative efforts at Merck & Company, Inc. highlight her importance in the advancement of therapeutics and underscore the role of inventors in shaping the future of medicine.